Can statins help protect against bushfire smoke?
Treatments studied
This trial tests if taking a common cholesterol-lowering medication (atorvastatin) can reduce the harmful effects of breathing in bushfire smoke. It's for generally healthy adults who are not at high risk for heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health
- You are 45 or older with a low to intermediate risk of heart disease (but not high risk)
- You do not have a serious lung disease like COPD or asthma
- You have never had a stroke, dementia, or other neurological condition
- You do not have diabetes or untreated high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the statin drug atorvastatin can prevent immunotherapy from worsening artery plaque in people with melanoma. It aims to lower the risk of heart problems caused by treatment.
This trial looks at how statins (cholesterol-lowering drugs) affect certain cells in healthy young adults. By participating, you help researchers understand how statins work in the body.
This trial studies whether cholesterol-lowering medicine (a statin, specifically atorvastatin) improves health and benefits in people age 75 and older in everyday life. It may help doctors understand which older adults benefit most and how to use these medicines safely.
This study tests whether statins, a common cholesterol-lowering medication, can improve erectile function and hormone levels in men at high risk for heart problems. It aims to see if these benefits exist beyond just lowering cholesterol.
This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.
This trial tests whether atorvastatin (a cholesterol medicine) can lower the chance of liver cancer (HCC) in people with advanced liver scarring or cirrhosis. Participants are compared to placebo (inactive pill) while researchers track safety and cancer risk.
Hear when a new Healthy Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.